Donna Hildebrand Kralowetz has sold SYNH and made no open-market buys since Feb 2021

Donna Hildebrand Kralowetz is a corporate finance executive who serves as Executive Vice President and Chief Accounting Officer of Syneos Health, Inc., a global clinical and commercial biopharmaceutical solutions organization.( She has held senior accounting leadership roles at Syneos Health over multiple years, including prior designation as Senior Vice President & Chief Accounting Officer, reflecting her progression within the company’s executive ranks.( As a named corporate officer and SEC-reporting insider, she is responsible for overseeing the company’s accounting policies, financial reporting, and internal controls in support of the Chief Financial Officer and broader leadership team.(

Kralowetz regularly appears in U.S. Securities and Exchange Commission filings as an insider of Syneos Health, reporting transactions in the company’s Class A common stock in her capacity as EVP, Chief Accounting Officer.( Public insider-trading records show multiple Form 4 filings and documented transactions from at least 2021 through 2023, underscoring her ongoing role as a key member of Syneos Health’s executive management and finance organization.( While detailed public information about her earlier career and formal education is limited, available records identify her as an experienced accounting and finance professional in her 50s based in Florida, consistent with a long tenure in corporate financial leadership.(

Written by Perplexity from public sources.